Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 13/2015

01.12.2015 | Original Article

Gastric injury from 90Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction?

verfasst von: Vanessa L. Gates, Ryan Hickey, Karen Marshall, Melissa Williams, Krystina Salzig, Robert J. Lewandowski, Riad Salem

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 13/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Radioembolization with 90Y microspheres is a locoregional radiation therapy for unresectable hepatic neoplasm. Non-target delivery of 90Y microspheres resulting in gastrointestinal (GI) symptoms is a recognized complication; there is minimal knowledge regarding the radiation effect to the gastric wall from left hepatic lobe 90Y treatments. Our aim was to study the incidence of GI complications when the target tissue (hepatic parenchyma ± tumor) is in close proximity to the gastric wall. We hypothesized that liver (tumor) to stomach proximity does not correlate with increased toxicity.

Methods

Between November 2011 and September 2013, we studied all patients who underwent left lobe radioembolization with 90Y glass microspheres. With Institutional Review Board (IRB) approval, we retrospectively reviewed MRI/CT images of these patients, identifying a subset of patients with the left hepatic lobe <1 cm from the gastric wall. Patients were seen in clinic 1 month posttreatment and subsequently at 3-month intervals. Short- and long-term gastric adverse events were tabulated.

Results

Ninety-seven patients successfully underwent left hepatic lobe 90Y microsphere radioembolization in which the average distance from the liver to the stomach wall was 1.0 ± 2.8 mm. The average dose for patients who received radioembolization to the left hepatic lobe was 109 ± 57 Gy. Fifty patients had tumor within 1 cm of the gastric wall. The average dose for patients who received radioembolization to the left hepatic lobe with tumor within 1 cm of the gastric wall was 121 ± 41 Gy. There were no reportable or recordable medical events. Of the patients, 34 % reported abdominal pain that was grade 1–2; 65 % of the patients reported no abdominal pain. None of the 97 patients developed a clinically evident GI ulcer.

Conclusion

Patients with left lobe tumors adjacent to or abutting the stomach do not exhibit acute or chronic radiation effects following radioembolization with glass microspheres.
Literatur
1.
Zurück zum Zitat Dezarn WA, Cessna JT, DeWerd LA, Feng W, Gates VL, Halama J, et al. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys 2011;38:4824–45.CrossRefPubMed Dezarn WA, Cessna JT, DeWerd LA, Feng W, Gates VL, Halama J, et al. Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys 2011;38:4824–45.CrossRefPubMed
2.
Zurück zum Zitat TheraSphere® (US package insert). Rev. 11 ed. Ottawa, ON, Canada: Nordion Inc.; 2011. TheraSphere® (US package insert). Rev. 11 ed. Ottawa, ON, Canada: Nordion Inc.; 2011.
3.
Zurück zum Zitat Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek Jr AA, Kulik L, et al. Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 2007;30:571–92. doi:10.1007/s00270-007-9064-z.CrossRefPubMed Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek Jr AA, Kulik L, et al. Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 2007;30:571–92. doi:10.​1007/​s00270-007-9064-z.CrossRefPubMed
5.
Zurück zum Zitat Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, et al. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med 2012;53:255–63. doi:10.2967/jnumed.111.094235.CrossRefPubMed Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, et al. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med 2012;53:255–63. doi:10.​2967/​jnumed.​111.​094235.CrossRefPubMed
6.
Zurück zum Zitat Bolch WE, Bouchet LG, Robertson JS, Wessels BW, Siegel JA, Howell RW, et al. MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. J Nucl Med 1999;40:11S–36S.PubMed Bolch WE, Bouchet LG, Robertson JS, Wessels BW, Siegel JA, Howell RW, et al. MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee. J Nucl Med 1999;40:11S–36S.PubMed
7.
Zurück zum Zitat Naymagon S, Warner RR, Patel K, Harpaz N, Machac J, Weintraub JL, et al. Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature. Dig Dis Sci 2010;55:2450–8. doi:10.1007/s10620-010-1156-y.CrossRefPubMed Naymagon S, Warner RR, Patel K, Harpaz N, Machac J, Weintraub JL, et al. Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature. Dig Dis Sci 2010;55:2450–8. doi:10.​1007/​s10620-010-1156-y.CrossRefPubMed
9.
Zurück zum Zitat Blanchard RJ, Morrow IM, Sutherland JB. Treatment of liver tumors with yttrium-90 microspheres alone. Can Assoc Radiol J 1989;40:206–10.PubMed Blanchard RJ, Morrow IM, Sutherland JB. Treatment of liver tumors with yttrium-90 microspheres alone. Can Assoc Radiol J 1989;40:206–10.PubMed
12.
13.
14.
15.
16.
18.
19.
Zurück zum Zitat Luo DL, Chan JK. Basophilic round bodies in gastric biopsies little known by pathologists: iatrogenic yttrium 90 microspheres deriving from selective internal radiation therapy. Int J Surg Pathol 2013;21:535–7. doi:10.1177/1066896913481057.CrossRefPubMed Luo DL, Chan JK. Basophilic round bodies in gastric biopsies little known by pathologists: iatrogenic yttrium 90 microspheres deriving from selective internal radiation therapy. Int J Surg Pathol 2013;21:535–7. doi:10.​1177/​1066896913481057​.CrossRefPubMed
20.
Zurück zum Zitat Chon YE, Seong J, Kim BK, Cha J, Kim SU, Park JY, et al. Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors. Int J Radiat Oncol Biol Phys 2011;81:1343–51. doi:10.1016/j.ijrobp.2010.07.1986.CrossRefPubMed Chon YE, Seong J, Kim BK, Cha J, Kim SU, Park JY, et al. Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors. Int J Radiat Oncol Biol Phys 2011;81:1343–51. doi:10.​1016/​j.​ijrobp.​2010.​07.​1986.CrossRefPubMed
21.
Zurück zum Zitat Yang MH, Lee JH, Choi MS, Park HS, Rhee PL, Kim JJ, et al. Gastrointestinal complications after radiation therapy in patients with hepatocellular carcinoma. Hepatogastroenterology 2005;52:1759–63.PubMed Yang MH, Lee JH, Choi MS, Park HS, Rhee PL, Kim JJ, et al. Gastrointestinal complications after radiation therapy in patients with hepatocellular carcinoma. Hepatogastroenterology 2005;52:1759–63.PubMed
22.
Zurück zum Zitat Yoon H, Oh D, Park HC, Kang SW, Han Y, Lim DH, et al. Predictive factors for gastroduodenal toxicity based on endoscopy following radiotherapy in patients with hepatocellular carcinoma. Strahlenther Onkol 2013;189:541–6. doi:10.1007/s00066-013-0343-0.CrossRefPubMed Yoon H, Oh D, Park HC, Kang SW, Han Y, Lim DH, et al. Predictive factors for gastroduodenal toxicity based on endoscopy following radiotherapy in patients with hepatocellular carcinoma. Strahlenther Onkol 2013;189:541–6. doi:10.​1007/​s00066-013-0343-0.CrossRefPubMed
23.
Zurück zum Zitat Streitparth F, Pech M, Böhmig M, Ruehl R, Peters N, Wieners G, et al. In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2006;65:1479–86. doi:10.1016/j.ijrobp.2006.02.052.CrossRefPubMed Streitparth F, Pech M, Böhmig M, Ruehl R, Peters N, Wieners G, et al. In vivo assessment of the gastric mucosal tolerance dose after single fraction, small volume irradiation of liver malignancies by computed tomography-guided, high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2006;65:1479–86. doi:10.​1016/​j.​ijrobp.​2006.​02.​052.CrossRefPubMed
Metadaten
Titel
Gastric injury from 90Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction?
verfasst von
Vanessa L. Gates
Ryan Hickey
Karen Marshall
Melissa Williams
Krystina Salzig
Robert J. Lewandowski
Riad Salem
Publikationsdatum
01.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 13/2015
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-015-3122-6

Weitere Artikel der Ausgabe 13/2015

European Journal of Nuclear Medicine and Molecular Imaging 13/2015 Zur Ausgabe